Sofosbuvir-ribavirin combo shows promise for hepatitis C

04/24/2013 | HealthDay News

A study in the New England Journal of Medicine found that combining hepatitis C treatment sofosbuvir with ribavirin for patients who cannot take interferon led to a 78% cure rate after three months of treatment. In patients unresponsive to interferon, the study observed a 73% cure rate after four months of treatment with the two-drug combo. Another study found cure rates of 67% for treatment with either sofosbuvir and ribavirin, or ribavirin and interferon.

View Full Article in:

HealthDay News

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Site Quality Management
CareFusion
Minneapolis, MN
Clinical Project Manager
Abiomed, Inc.
Danvers, MA
Sr. Manager, Regulatory Affairs - International
Integra LifeSciences
Plainsboro, NJ
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC
In house Compliance Officer
Confidential
Pompano Beach, FL